ArticleFrontiers in nutrition2026
Early-pregnancy serum iron as a nutrition-related clinical laboratory indicator for preeclampsia risk stratification: a retrospective cohort study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Nutrition-related clinical laboratory indicators are valuable for risk assessment, early identification, and precision management in obstetric and gynecologic diseases. Serum iron, a commonly used laboratory marker reflecting iron metabolism status, has shown inconsistent associations with preeclampsia (PE). Objective: To investigate the association between early-pregnancy serum iron levels and the risk of PE, and to evaluate their associations with low birth weight, cesarean delivery, and preterm birth. Methods: This single-center retrospective cohort study included 37,643 pregnant women. Early-pregnancy serum iron level was the exposure variable, PE the primary outcome, and low birth weight, cesarean delivery, and preterm birth secondary outcomes. Logistic regression models (non-adjusted, Adjust I, and Adjust II) assessed associations between serum iron and each outcome. Smooth curve fitting illustrated the relationship between serum iron and PE risk. Stratified analyses by age, BMI, and parity, along with interaction analysis, evaluated the robustness of the association. Results: Serum iron levels were lower in the PE group than in the non-PE group (20.45 ± 6.16 vs. 21.32 ± 6.11 μmol/L, Conclusion: Higher early-pregnancy serum iron levels were significantly associated with lower risk of PE, although its clinical utility still requires further validation in prospective studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.